Experimental coronavirus drug remdesivir to be distributed again after halt a week ago
Business

Experiments going on for a coronavirus vaccine

An experimental coronavirus treatment that was halted a week ago due to "overwhelming" demand is once again available to doctors under an expanded access program. On Saturday, Gilead Sciences CEO Daniel O’Day announced in an open letter that his company was once again making remdesivir available outside of the six ongoing clinical trials investigating whether it is effective as a treatment for COVID-19

drug treatment week

Sun Mar 29 - Google

Related Articles

Anti-viral drug remdesivir effective against coronavirus, study finds
Business
Remdesivir helps against coronavirus, study finds

Anti-viral drug remdesivir cuts recovery times in coronavirus patients, according to the full results of a trial published Friday night, three weeks after America's top infectious diseases expert said the study showed the medication has "clear-cut" benefits. Remdesivir for the Treatment of Covid-19—Preliminary Report, New England Journal of Medicine (2020) mentioned the findings.

treatment hospitalized niaid

Sat May 23 - Medicalxpress
Drug tested at UVA cleared as 1st COVID-19 treatment
Business
Drug tested at UVA cleared as 1st COVID-19 treatment

“We are immensely grateful to the patients who participated in this important clinical trial and their families,” said Patrick Jackson, MD, the trial’s principal investigator at UVA. Tested at UVA Health and 67 other sites around the world, remdesivir helped patients with advanced cases of COVID-19 recover 31% faster than patients who received a placebo, according to preliminary trial results released by the National Institutes of Health.

drug

Sun May 03 - Whsv
If You Invested $1,000 in Gilead Sciences' IPO, This Is How Much Money You'd Have Now
Business
If You Invested $1,000 in Gilead Sciences' IPO, This Is How Much Money You'd Have Now

Gilead Sciences priced its shares at $15 before its IPO. Still, though, a $10,000 investment in Gilead's IPO would now be worth nearly $1.8 million. Vistide was the beginning of a long and successful road for Gilead in treating HIV-related conditions. Gilead is also evaluating drugs that could potentially cure HIV in early stage clinical studies.

ipo drug gileads

Sun Apr 19 - Google
Miami's First Coronavirus Death, 40-Year-Old Who Went to Miami Dance Party
Business
40-Year-Old Who Went to Miami Dance Party died due to Coronavirus

Earlier this month, Israel Carreras and his boyfriend, Franco, attended the Winter Party Festival in Miami along the shores of Nikki Beach, South Beach and others between the dates of March 4 and March 10. Israel developed COVID19 symptoms after a few days and died in Miami-area hospital on Friday night. At least 9 other people, so far, who attended Winter Party Festival have reportedly contracted COVID-19 as well.

party week covid19

Sun Mar 29 - Google